Sandbox:Usman Shah: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
| | | | ||
[[File:800px-Covid-19 San Salvatore 02.jpg|thumb|300px|none|Covid19 healthcare worker. [https://commons.wikimedia.org/w/index.php?search=covid&title=Special%3ASearch&go=Go&ns0=1&ns6=1&ns12=1&ns14=1&ns100=1&ns106=1#/media/File:Covid-19_San_Salvatore_02.jpg]]] | [[File:800px-Covid-19 San Salvatore 02.jpg|thumb|300px|none|Covid19 healthcare worker. [https://commons.wikimedia.org/w/index.php?search=covid&title=Special%3ASearch&go=Go&ns0=1&ns6=1&ns12=1&ns14=1&ns100=1&ns106=1#/media/File:Covid-19_San_Salvatore_02.jpg]]] | ||
|} | |||
{| | |||
|+ '''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders''' | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | - | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration | |||
| style="background:#F5F5F5;" align="center" + | + | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | - | |||
| style="background:#F5F5F5;" align="center" + | - | |||
|} |
Revision as of 16:29, 17 July 2020
Practice here
Criteria | Symptomatic WM | Asymptomatic WM | IgM-Related Disorders | MGUS |
---|---|---|---|---|
IgM monoclonal protein | + | + | + | + |
Bone marrow infiltration | + | + | - | - |
Symptoms attributable to IgM | + | - | + | - |
Symptoms attributable to tumor infiltration | + | - | - | - |